|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Center for Research Resources (NCRR) |
|---|---|
| Collaborator: |
Children's Hospital of Philadelphia |
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00008736 |
Purpose
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
| Condition | Intervention | Phase |
|---|---|---|
|
Infant, Newborn, Diseases |
Drug: metoclopramide |
Phase II |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Primary Purpose: Treatment |
| Official Title: | Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide |
Eligibility| Ages Eligible for Study: | up to 1 Month |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion:
Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00008736 History of Changes |
| Other Study ID Numbers: | NCRR-M01RR00240-1724 |
| Study First Received: | January 16, 2001 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
|
Feeding intolerance Infant, premature |
|
Infant, Newborn, Diseases Metoclopramide Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Gastrointestinal Agents Dopamine Antagonists Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |